EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 5.802
June 30, 2026 0.5509
March 31, 2026 2.171
December 31, 2025 2.720
September 30, 2025 4.374
June 30, 2025 10.60
March 31, 2025 9.038
December 31, 2024 8.915
September 30, 2024 7.934
June 30, 2024 7.351
March 31, 2024 7.757
December 31, 2023 7.388
September 30, 2023 6.208
June 30, 2023 6.177
March 31, 2023 6.184
December 31, 2022 6.127
September 30, 2022 5.626
June 30, 2022 2.518
March 31, 2022 2.495
December 31, 2021 2.962
September 30, 2021 3.938
June 30, 2021 6.828
March 31, 2021 6.345
December 31, 2020 6.224
September 30, 2020 6.150
Date Value
June 30, 2020 6.166
March 31, 2020 6.952
December 31, 2019 6.882
September 30, 2019 6.674
June 30, 2019 6.476
March 31, 2019 6.099
December 31, 2018 5.888
September 30, 2018 5.570
June 30, 2018 5.380
March 31, 2018 5.260
December 31, 2017 5.13
September 30, 2017 5.16
June 30, 2017 4.94
March 31, 2017 4.83
December 31, 2016 4.66
September 30, 2016 4.44
June 30, 2016 4.33
March 31, 2016 4.20
December 31, 2015 3.98
September 30, 2015 3.60
June 30, 2015 3.37
March 31, 2015 3.06
December 31, 2014 2.73
September 30, 2014 2.53
June 30, 2014 2.19

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Medpace Holdings, Inc. 18.04
Proteome Sciences Plc -0.0055
Champions Oncology, Inc. -0.0802
Avantor, Inc. 0.4961
Personalis, Inc. -1.162